LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers.

    Smrke, Alannah / Younger, Eugenie / Wilson, Roger / Husson, Olga / Farag, Sheima / Merry, Eve / Macklin-Doherty, Aislinn / Cojocaru, Elena / Arthur, Amani / Benson, Charlotte / Miah, Aisha B / Zaidi, Shane / Gennatas, Spyridon / Jones, Robin L

    JCO global oncology

    2020  Volume 6, Page(s) 1046–1051

    Abstract: ... distances to access expert care. The COVID-19 pandemic necessitated widespread changes in delivery of cancer ... of telemedicine on patients, clinicians, and care delivery at the Royal Marsden Hospital (RMH) Sarcoma Unit during ... can revolutionize delivery of cancer care, particularly for patients with rare cancers who often live far away ...

    Abstract Purpose: Many patients with cancer, often those with rare cancers such as sarcomas, travel long distances to access expert care. The COVID-19 pandemic necessitated widespread changes in delivery of cancer care, including rapid adoption of telemedicine-based care. We aimed to evaluate the impact of telemedicine on patients, clinicians, and care delivery at the Royal Marsden Hospital (RMH) Sarcoma Unit during the pandemic.
    Methods: Data were extracted from patient records for all planned outpatient appointments at the RMH Sarcoma Unit from March 23 to April 24, 2020. Patients and clinicians completed separate questionnaires to understand their experiences.
    Results: Of 379 planned face-to-face appointments, 283 (75%) were converted to telemedicine. Face-to-face appointments remained for patients who needed urgent start of therapy or performance status assessment. Patients lived on average > 1.5 hours from RMH. Patient satisfaction (n = 108) with telemedicine was high (mean, 9/10), and only 48% (n = 52/108) would not want to hear bad news using telemedicine. Clinicians found telemedicine efficient, with no associated increased workload, compared with face-to-face appointments. Clinicians indicated lack of physical examination did not often affect care provision when using telemedicine. Most clinicians (n = 17; 94%) believed telemedicine use was practice changing; congruently, 80% (n = 86/108) of patients desired some telemedicine as part of their future care, citing reduced cost and travel time.
    Conclusion: Telemedicine can revolutionize delivery of cancer care, particularly for patients with rare cancers who often live far away from expert centers. Our study demonstrates important patient and clinician benefits; assessment of longer-term impact on patient outcomes and health care systems is needed.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Ambulatory Care/methods ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/epidemiology ; Delivery of Health Care/methods ; Female ; Gastrointestinal Neoplasms/therapy ; Gastrointestinal Stromal Tumors/therapy ; Humans ; Male ; Medical Oncology/methods ; Middle Aged ; Pandemics ; Patient Satisfaction ; Pneumonia, Viral/epidemiology ; Retrospective Studies ; SARS-CoV-2 ; Sarcoma/therapy ; Soft Tissue Neoplasms/therapy ; Telemedicine/methods ; Travel ; United Kingdom/epidemiology ; Workload ; Young Adult
    Keywords covid19
    Language English
    Publishing date 2020-07-08
    Publishing country United States
    Document type Journal Article
    ISSN 2687-8941
    ISSN (online) 2687-8941
    DOI 10.1200/GO.20.00220
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers

    Smrke, Alannah / Younger, Eugenie / Wilson, Roger / Husson, Olga / Farag, Sheima / Merry, Eve / Macklin-Doherty, Aislinn / Cojocaru, Elena / Arthur, Amani / Benson, Charlotte / Miah, Aisha B / Zaidi, Shane / Gennatas, Spyridon / Jones, Robin L

    JCO Glob Oncol

    Abstract: ... distances to access expert care. The COVID-19 pandemic necessitated widespread changes in delivery of cancer ... of telemedicine on patients, clinicians, and care delivery at the Royal Marsden Hospital (RMH) Sarcoma Unit during ... can revolutionize delivery of cancer care, particularly for patients with rare cancers who often live far away ...

    Abstract PURPOSE: Many patients with cancer, often those with rare cancers such as sarcomas, travel long distances to access expert care. The COVID-19 pandemic necessitated widespread changes in delivery of cancer care, including rapid adoption of telemedicine-based care. We aimed to evaluate the impact of telemedicine on patients, clinicians, and care delivery at the Royal Marsden Hospital (RMH) Sarcoma Unit during the pandemic. METHODS: Data were extracted from patient records for all planned outpatient appointments at the RMH Sarcoma Unit from March 23 to April 24, 2020. Patients and clinicians completed separate questionnaires to understand their experiences. RESULTS: Of 379 planned face-to-face appointments, 283 (75%) were converted to telemedicine. Face-to-face appointments remained for patients who needed urgent start of therapy or performance status assessment. Patients lived on average > 1.5 hours from RMH. Patient satisfaction (n = 108) with telemedicine was high (mean, 9/10), and only 48% (n = 52/108) would not want to hear bad news using telemedicine. Clinicians found telemedicine efficient, with no associated increased workload, compared with face-to-face appointments. Clinicians indicated lack of physical examination did not often affect care provision when using telemedicine. Most clinicians (n = 17; 94%) believed telemedicine use was practice changing; congruently, 80% (n = 86/108) of patients desired some telemedicine as part of their future care, citing reduced cost and travel time. CONCLUSION: Telemedicine can revolutionize delivery of cancer care, particularly for patients with rare cancers who often live far away from expert centers. Our study demonstrates important patient and clinician benefits; assessment of longer-term impact on patient outcomes and health care systems is needed.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #638037
    Database COVID19

    Kategorien

  3. Article ; Online: What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.

    McCabe, Holly M / Smrke, Alannah / Cowie, Fiona / White, Jeff / Chong, Peter / Lo, Steven / Mahendra, Ashish / Gupta, Sanjay / Ferguson, Michelle / Boddie, David / Mmekka, Walter / Stirling, Lorraine / Campbell, Lindsay / Jones, Robin L / Nixon, Ioanna

    JCO global oncology

    2021  Volume 7, Page(s) 1067–1073

    Abstract: ... The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer ... and patient perspectives. Utilization of telemedicine for patients with rare cancers such as sarcomas ... of telemedicine appointments (57%).: Conclusion: Telemedicine in sarcoma care is favorable from both clinician ...

    Abstract Purpose: In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Cancer Centre Sarcoma Unit.
    Methods: Between June 8 and August 25, 2020, we invited patients and professional sarcoma multidisciplinary team members to participate in separate online anonymous survey questionnaires, to assess their attitudes toward telemedicine. Data were extracted, and descriptive statistics were performed.
    Results: Patient satisfaction (n = 64) with telemedicine was high (mean = 9.4/10) and comparable with traditional face-to-face appointments (mean = 9.5/10). Patients were receptive to the use of telemedicine in certain situations, with patients strongly opposed to being told bad news via telemedicine (88%). Providers recommended the use of telemedicine in certain patient populations and reported largely equivalent workloads when compared with traditional consultations. Providers reported that telemedicine should be integrated into regular practice (66%), with patients echoing this indicating a preference for a majority of telemedicine appointments (57%).
    Conclusion: Telemedicine in sarcoma care is favorable from both clinician and patient perspectives. Utilization of telemedicine for patients with rare cancers such as sarcomas is an innovative approach to the delivery of care, especially considering the time and financial pressures on patients who often live a distance away from specialist centers. Patients and providers are keen to move toward a more flexible, mixed system of care.
    MeSH term(s) COVID-19 ; Humans ; Pandemics ; Patient Satisfaction ; SARS-CoV-2 ; Sarcoma/epidemiology ; Sarcoma/therapy ; Scotland/epidemiology ; Telemedicine
    Language English
    Publishing date 2021-06-29
    Publishing country United States
    Document type Journal Article
    ISSN 2687-8941
    ISSN (online) 2687-8941
    DOI 10.1200/GO.20.00599
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top